Evidence map›Paper›PMID 22937151›Full record

ArticlePloS one2012

Involvement of AMPA receptor GluR2 and GluR3 trafficking in trigeminal spinal subnucleus caudalis and C1/C2 neurons in acute-facial inflammatory pain.

Makiko Miyamoto, Yoshiyuki Tsuboi, Kuniya Honda, Masayuki Kobayashi, Kogo Takamiya, Richard L Huganir, Masahiro Kondo, Masamichi Shinoda, Barry J Sessle, Ayano Katagiri and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.Journal of neural transmission (Vienna, Austria : 1996) · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Makiko MiyamotoDepartment of Anesthesiology, Nihon University School of Dentistry, Kandasurugadai, Chiyoda-ku, Tokyo, Japan.
Yoshiyuki Tsuboi
Kuniya Honda
Masayuki Kobayashi
Kogo Takamiya
Richard L Huganir
Masahiro Kondo
Masamichi Shinoda
Barry J Sessle
Ayano Katagiri
Daiju Kita
Ikuko Suzuki
Yoshiyuki Oi
Koichi Iwata
Nihon University · JPHoward Hughes Medical Institute · USUniversity of Miyazaki · JPUniversity of Toronto · CA

Funding

PERIPHERAL NMDA RECEPTORS AND TMD PAIN MECHANISMSR01DE015420 · NIDCR · UNIVERSITY OF TORONTO · PI SESSLE, BARRY J. · 2003 to 2006
$1.2M
CIHRNIDCR NIH HHS DE015420NIDCR NIH HHS R01 DE015420
6 · The paper itself

Abstract

To evaluate the involvement of trafficking of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) GluR2 and GluR3 subunits in an acute inflammatory orofacial pain, we analyzed nocifensive behavior, phosphorylated extracellular signal-regulated kinase (pERK) and Fos expression in Vi/Vc, Vc and C1/C2 in GluR2 delta7 knock-in (KI), GluR3 delta7 KI mice and wild-type mice. We also studied Vc neuronal activity to address the hypothesis that trafficking of GluR2 and GluR3 subunits plays an important role in Vi/Vc, Vc and C1/C2 neuronal activity associated with orofacial inflammation in these mice. Late nocifensive behavior was significantly depressed in GluR2 delta7 KI and GluR3 delta7 KI mice. In addition, the number of pERK-immunoreactive (IR) cells was significantly decreased bilaterally in the Vi/Vc, Vc and C1/C2 in GluR2 delta7 KI and GluR3 delta7 KI mice compared to wild-type mice at 40 min after formalin injection, and was also significantly smaller in GluR3 delta7 KI compared to GluR2 delta7 KI mice. The number of Fos protein-IR cells in the ipsilateral Vi/Vc, Vc and C1/C2 was also significantly smaller in GluR2 delta7 KI and GluR3 delta7 KI mice compared to wild-type mice 40 min after formalin injection. Nociceptive neurons functionally identified as wide dynamic range neurons in the Vc, where pERK- and Fos protein-IR cell expression was prominent, showed significantly lower spontaneous activity in GluR2 delta7 KI and GluR3 delta7 KI mice than wild-type mice following formalin injection. These findings suggest that GluR2 and GluR3 trafficking is involved in the enhancement of Vi/Vc, Vc and C1/C2 nociceptive neuronal excitabilities at 16-60 min following formalin injection, resulting in orofacial inflammatory pain.

Indexed as

6-Cyano-7-nitroquinoxaline-2,3-dioneAcute PainAnimalsBehavior, AnimalExtracellular Signal-Regulated MAP KinasesFacial PainInflammationMiceMice, TransgenicNociceptorsPain MeasurementPhosphorylationReceptors, AMPATrigeminal Caudal Nucleus6-Cyano-7-nitroquinoxaline-2,3-dioneExtracellular Signal-Regulated MAP Kinasesglutamate receptor ionotropic, AMPA 2glutamate receptor ionotropic, AMPA 3Receptors, AMPA

Identifiers

PMID22937151
PMCPMC3427165
OpenAlexW2158026299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.